Advertisement
Loading...

Kezar Life Sciences, Inc.

KZR•NASDAQ
Healthcare
Biotechnology
$7.29
$0.00(0.00%)
U.S. Market opens in 5h 47m

Kezar Life Sciences, Inc. (KZR) Stock Overview

Explore Kezar Life Sciences, Inc.’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

Z

Key Financials

Market Cap53.9M
P/E Ratio-1.18
EPS (TTM)$-7.66
ROE-0.58%
Fundamental Analysis

AI Price Forecasts

1 Month$5.33
3 Months$16.02
1 Year Target$24.91

KZR Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of Kezar Life Sciences, Inc. (KZR) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of C+, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 52.42, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $24.91.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of -1.18 and a market capitalization of 53.9M. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
N/A
5-Day Change
-0.82%
1-Month Change
-1.09%
3-Month Change
14.98%
6-Month Change
17.96%
Year-to-Date (YTD) Change
15.90%
1-Year Change
72.34%
3-Year Change
-97.20%
5-Year Change
-98.56%
All-Time (Max) Change
-99.59%

Contact Information

https://www.kezarlifesciences.com
650 822 5600
4000 Shoreline Court, South San Francisco, CA, 94080

Company Facts

55 Employees
IPO DateJun 21, 2018
CountryUS
Actively Trading

Frequently Asked Questions